Strive Specialties, one of the largest compounding pharmacies in the country, accused Eli Lilly and Novo Nordisk of locking up telehealth companies they partner with in an effort to cut off businesse… [+2509 chars]
Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s - Sherwood News
Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.
By:J. Edward Moreno
Source:Sherwood.news
Published:
Related News
Alibaba-backed startup Moonshot AI's valuation is up $500 million, sources say, after its rivals IPO in Hong Kong - CNBC
Investors are valuing the startup at $4.8 billion as it is about to close another funding round, according to two people familiar with the matter.
CNBC•Evelyn Cheng
Stellantis stock off 43% as Jeep maker turns five, executes turnaround - CNBC
Stellantis shares were largely up – as high as 93% in March 2024 – until reporting troubling financial results that year amid cost-cutting efforts and EVs.
CNBC•Michael Wayland
10 things I learned from burning myself out with AI coding agents - Ars Technica
Opinion: As software power tools, AI agents may make people busier than ever before.
Ars Technica•Benj Edwards